[Ethylene oxide and cancer]. 1991

J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
Servicio de Medicina Preventiva, Hospital Miguel Servet, Zaragoza.

UI MeSH Term Description Entries
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005027 Ethylene Oxide A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794) Oxirane,Oxide, Ethylene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015197 Carcinogenicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Tumorigenicity Tests,Carcinogen Tests,Carcinogenesis Tests,Carcinogenic Activity Tests,Carcinogenic Potency Tests,Carcinogen Test,Carcinogenesis Test,Carcinogenic Activity Test,Carcinogenic Potency Test,Carcinogenicity Test,Potency Test, Carcinogenic,Potency Tests, Carcinogenic,Test, Carcinogen,Test, Carcinogenesis,Test, Carcinogenic Activity,Test, Carcinogenic Potency,Test, Carcinogenicity,Test, Tumorigenicity,Tests, Carcinogen,Tests, Carcinogenesis,Tests, Carcinogenic Activity,Tests, Carcinogenic Potency,Tests, Carcinogenicity,Tests, Tumorigenicity,Tumorigenicity Test

Related Publications

J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
October 1986, JAMA,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
January 2004, Occupational and environmental medicine,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
June 1996, International journal of epidemiology,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
May 1965, Journal of pharmaceutical sciences,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
April 1993, British journal of industrial medicine,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
November 1981, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
November 2012, ACS macro letters,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
January 2004, Report on carcinogens : carcinogen profiles,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
January 1976, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man,
J I Barrasa Villar, and J L Arribas Llorente, and J R García Mata, and M J Amorín Calzada
January 1982, Hospital topics,
Copied contents to your clipboard!